Results 131 to 140 of about 287,802 (318)

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

Haematologica, 2018
The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia.
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto   +13 more
doaj   +1 more source

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

Blood Cancer Journal, 2018
Polycythemia vera is characterized by the acquisition of the JAK2V617F mutation. Recommended treatments include hydroxyurea and interferon-alpha. Several groups have reported a reduction in the JAK2 mutant allele burden in interferon-treated patients ...
E. Verger, J. Soret-Dulphy, N. Maslah, L. Roy, J. Rey, Z. Ghrieb, R. Kralovics, H. Gisslinger, B. Grohmann-Izay, C. Klade, C. Chomienne, S. Giraudier, B. Cassinat, J. Kiladjian   +13 more
semanticscholar   +1 more source

In vivo localization of colloidal Au198 intravenously injected in polycythemia vera [PDF]

, 1958
L. Engstedt, S. Franzén, Lars Jonsson, Lars‐Gunnar Larsson   +3 more
openalex   +1 more source

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis

Cancer Medicine, 2018
Interferon‐α2 reduces elevated blood cell counts and splenomegaly in patients with myeloproliferative neoplasms (MPN) and may restore polyclonal hematopoiesis.
S. U. Mikkelsen, L. Kjaer, M. E. Bjørn, T. Knudsen, A. Sørensen, C. Andersen, O. Bjerrum, Nana Brochmann, D. Fassi, T. Kruse, T. Larsen, H. T. Mourits-Andersen, C. Nielsen, N. Pallisgaard, M. Thomassen, V. Skov, H. Hasselbalch   +16 more
semanticscholar   +1 more source

Chronic myelomonocytic leukemia as a transformation from polycythemia vera

Leukemia Research Reports, 2019
The hallmark of Polycythemia vera (PV) is the presence of JAK2V617F mutation and increased RBC mass. Chronic myelomonocytic leukemia (CMML) is defined as persistent blood absolute monocyte count (AMC) >/= 1 × 109/L for at least 3 months with myeloid cell
Mirela Andrei, Anita Pandey, Boris Avezbakiyev, Jen Chin Wang   +3 more
doaj   +1 more source

CLINICAL STUDIES OF THE BLOOD VOLUME. VIII. MACROCYTIC AND HYPOCHROMIC ANEMIAS DUE TO CHRONIC BLOOD LOSS, HEMOLYSIS AND MISCELLANEOUS CAUSES, AND POLYCYTHEMIA VERA 1 [PDF]

, 1939
John G. Gibson, Alfred W. Harris, Verne W. Swigert   +2 more
openalex   +1 more source

Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Haematologica, 2014
The clinical course of polycythemia vera and essential thrombocythemia is potentially associated with long-term severe complications, such as evolution to myelofibrosis or acute myeloid leukemia. Allogeneic stem cell transplantation is currently the only
Federico Lussana, Alessandro Rambaldi, Maria Chiara Finazzi, Anja van Biezen, Marijke Scholten, Elena Oldani, Alessandra Carobbio, Simona Iacobelli, Jurgen Finke, Arnon Nagler, Liisa Volin, Thierry Lamy, Renate Arnold, Mohamad Mohty, Mauricette Michallet, Theo de Witte, Eduardo Olavarria, Nicolaus Kröger   +17 more
doaj   +1 more source

STAT1 activation in association with JAK2 exon 12 mutations [PDF]

, 2015
La inclusión de la perspectiva de género en la actividad jurisdiccional es una demanda sostenida de los colectivos feministas y de mujeres, dado que las sentencias tienen un poder performativo y envían un mensaje a la sociedad: “[…] tienen un poder ...
Godfrey, A.L., Chen, E., Massie, C.E., Silber, Y., Pagano, F., Bellosillo, B., Guglielmelli, P., Harrison, C.N., Reilly, J.T., Stegelmann, F., Bijou, F., Lippert, E., Boiron, J.M., Dohner, K., Vannucchi, A.M., Besses, C., Green, A.R., Godfrey, A.L., Chen, E., Massie, C.E., Silber, Y., Pagano, F., Bellosillo, B., Guglielmelli, P., Harrison, C.N., Reilly, J.T., Stegelmann, F., Bijou, F., Lippert, E., Boiron, J.M., Dohner, K., Vannucchi, A.M., Besses, C., Green, A.R.   +33 more
core   +4 more sources

PULMONARY GAS DIFFUSION IN POLYCYTHEMIA VERA [PDF]

, 1927
George A. Harrop, Elmer H. Heath, Bianca Schaub   +2 more
openalex   +1 more source

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Leukemia, 2021
G. Abu-Zeinah, S. Krichevsky, Tatiana Cruz, Gabriela Hoberman, Diana Jaber, N. Savage, Claudia Sosner, E. Ritchie, J. Scandura, R. Silver   +9 more
semanticscholar   +1 more source